Moreover, JAK2V617F is the most common driving mutation in myeloproliferative neoplasms, which can accelerate Ang II‐induced AAA formation by promoting macrophage infiltration and the secretion of Mmp‐2, ‐9, and ‐13.156. Here, MMP2 is linked to triple-A syndrome.